Retinal Ischemic Perivascular lesions Linked to Myocardial Infarction Risk in CAD Patients: Study Dr Riya Dave1 April 2024 1:30 AM ISTCoronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide, with myocardial infarction (MI) posing a significant risk...
Evergreen Talk Series: How can Safety and Tolerability of Linagliptin and Dapagliflozin benefit diverse T2DM population? MD Brand Connect25 March 2024 4:38 PM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Lower risk of death, major adverse cardiovascular events in hyperthyroid patients treated with surgery than with medication Dr. Kamal Kant Kohli6 March 2024 12:45 AM ISTHyperthyroidism, or overactive thyroid, happens when your thyroid gland makes more thyroid hormones than your body needs. Excessive thyroid hormones...
Dysfunctional blood monocytes may predict CVD risk in patients with type 2 diabetes: Study Medha Baranwal5 March 2024 11:45 PM ISTFrance: A recent study published in Circulation Research has revealed that frequency and monocyte phenotypic profile are closely associated with...
Evergreen Talk Series: Combination of Linagliptin and Dapagliflozin in T2DM with multiple episodes of hypoglycemia MDTV Bureau21 Feb 2024 9:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Genetic testing for familial hypercholesterolemia may help refine risk stratification beyond LDL-C alone: JAMA Medha Baranwal5 Feb 2024 10:15 AM ISTUSA: A recent study published in JAMA Cardiology has revealed an association between the presence of familial hypercholesterolemia (FH) variants and a...
Evergreen Talk Series: Use of SGLT2i and DPP4i combination in T2DM patients with a history of Genitourinary Tract Infections MD Brand Connect1 Feb 2024 10:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
CDSCO Panel Grants Novartis Protocol Amendment Proposal For anti-cholesterol drug Inclisiran Dr. Divya Colin28 Jan 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Evergreen Talk Series: Position paper published in JAPI indicated that Linagliptin is simplifying T2DM management in a Wide Range of Patients MDTV Bureau23 Jan 2024 11:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Evergreen Talk Series: Clinical Considerations for Linagliptin and its combinations with Metformin, Dapagliflozin MD Brand Connect2 Jan 2024 11:00 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Extended use of inclisiran safe and efficacious among refractory dyslipidemia in patients with increased CV risk Dr Riya Dave29 Dec 2023 8:45 PM ISTA recent study sheds light on the safety profile of inclisiran, an innovative agent designed to reduce low-density lipoprotein cholesterol (LDL-C)....
Evergreen Talk Series: Linagliptin and Dapagliflozin combination for T2DM with Cardiovascular risk or established ASCVD MD Brand Connect21 Dec 2023 11:45 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr. Sameer I. Dani,...
